A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma

NCT06799676 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Multiple Myeloma

Interventions

DRUG: a combination treatment of Linperlisib and the VRD regimen

Sponsor

Fuling Zhou